October 2011

October 2011 header

Welcome to Research Roundup

Welcome to PH Research Roundup, a resource for members of PH Clinicians and Researchers (PHCR) and PH Professional Network, provided by the Pulmonary Hypertension Association.

researcher in lab

Does the Roundup meet your needs?

Please take our brief survey and let us know if PH Research Roundup is keeping you up-to-date with cutting edge opportunities in the field.
» Take the survey

What's In This Issue

» National Institutes of Health
(NIH) Grants
» PHA Research Opportunities
» Industry Sponsored Grants

» Medical Education Events
» News and Information

National Institutes of Health (NIH) Grants

Pulmonary Vascular-Right Ventricular Axis Research Program (R01)

(RFA HL-12-021)
National Heart, Lung, and Blood Institute
Submission Deadline: October 31, 2011


NIH Director's Transformative Research Awards (R01)

National Institutes of Health
Submission Deadline: January 12, 2012


Ancillary Studies in Clinical Trials (R01)

National Heart, Lung, and Blood Institute
Submission Deadline: January 27, 2012


Phase II Clinical Trials of Novel Therapies for Lung Diseases (UM1)

National Heart, Lung, and Blood Institute
Submission Deadlines
: February 15, 2012; September 13, 2012


Maximizing the Scientific Value of the NHLBI Biologic Specimen Repository: Scientific Opportunities (R21)

National Heart, Lung, and Blood Institute
Submission Deadline: May 4, 2012


Biomarkers: Bridging Pediatric and Adult Therapeutics (R03)

Eunice Kennedy Shriver National Institute of Child Health and Human Development
Submission Deadline: Standard dates apply, by 5:00 p.m. local time of applicant organization



Biomarkers: Bridging Pediatric and Adult Therapeutics (R01)

Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of General Medical Sciences
National Institute of Nursing Research Institute
Submission Deadline: Standard dates apply, by 5:00 p.m. local time of applicant organization

Biomarkers: Bridging Pediatric and Adult Therapeutics (R21)

Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Nursing Research
Submission Deadline: Standard dates apply, by 5:00 p.m. local time of applicant organization


NHLBI Clinical Trial Pilot Studies (R34)

National Heart, Lung, and Blood Institute
Submission Deadline: See website


Nutrition and Physical Activity Research to Promote Cardiovascular and Pulmonary Health (R01), (R21)

National Heart, Lung, and Blood Institute
Submission Deadline: See website

PHA Research Opportunities

2012 PHA Research Room

June 22-24, 2012
Orlando, Florida

PHA is now accepting applications for the Research Room at our 2012 International PH Conference and Scientific Sessions. The Research Room was established to further PH research by allowing for the collection of data and biological specimens (e.g. cheek swabs, blood samples) from PH patients. This event provides a rare opportunity for researchers to collect data from a remarkably high concentration of PH patients in one place, at one time.

Fill out an online application, or visit the Conference website for more information.


Call for Abstracts

Submit your abstract for the poster session at PHA's 10th International Pulmonary Hypertension Conference and Scientific Sessions in the areas of clinical science (including treatment) and basic science. Four abstracts will be selected for oral presentation and an award will be given to the top two abstracts. Summaries of top presentations will be published in a future issue of Advances in Pulmonary Hypertension. Although PHA encourages the submission of original abstracts, abstracts submitted to PHA do not need to be based on original work. Submit your abstract to
Read more about submission guidelines and download a conflict of interest form
Submission Deadline: March 15, 2012

Industry Sponsored Grants

Investigator-Sponsored Research

Through this program Gilead supports investigator-sponsored research conducted by third parties on Gilead's marketed products or within therapeutic areas of interest to the company.
Rolling Submissions
Read more


Entelligence Young Investigators Award Program

ENTELLIGENCE is a program for basic science, translation, and/or clinical research in the field of cardiopulmonary medicine. The program provides opportunities for individual young investigators to promote quality medical care and enhance patients' lives by supporting research in pulmonary hypertension (PH) related to expanding our knowledge of the pathways involved in pulmonary vascular pathobiology. ENTELLIGENCE is led by a Steering Committee comprised of leaders in the field of PH. The ENTELLIGENCETM program is supported through an educational grant from Actelion Pharmaceuticals US, Inc.
More about the ENTELLIGENCE Program


PCORI Pilot Projects Grant Program

The purpose of the Patient-Centered Outcomes Research Insitute (PCORI) Pilot Projects Grant Program is threefold. First, the applications themselves will assist PCORI with ongoing development and enhancement of national research priorities for patient-centered outcomes research. Applicants will be expected to establish the significance of the proposed research and build a case for why it should be considered a guiding question for PCORI.

Second, the PCORI Pilot Projects Grant Program will support the collection of preliminary data that can be used to advance the field of patient-centered outcomes research, providing the platform for a future PCORI research agenda. Third, the PCORI Pilot Projects Grant Program will support the identification of methodologies that can be used to advance patient-centered outcomes research as well as identify gaps where methodological research needs further development.
Submission Deadline: Letters of intent must be received by November 1, 2011, and applications must be received by December 1, 2011.
Read more

Medical Education Events

PHA Building Medical Education in PH (BME) Program

PHA's Building Medical Education in PH (BME) program creates a partnership between PHA and medical professionals planning CME-accredited educational programs. The BME program can enhance the planning of educational events concerning PH diagnosis and treatment by providing the tools that will increase their visibility, educational resources and prestige. Read more

Registration is currently open for the following BME events:

» November 6-8, 2011: 8th Annual Pulmonary Hypertension Summit, Cleveland Clinic, Cleveland, Ohio
» November 11, 2011: 3rd Annual UNC-Duke Research Triangle Pulmonary Hypertension Symposium, Durham, N.C. 
» November 15, 2011: Pulmonary Hypertension: How to Recognize It, How to Treat it, Lansing, Kans.
» December 2, 2011: 9th Annual Update in Pulmonary Hypertension, Tufts University School of Medicine, Tufts Medical Center, Cambridge, Mass.

To learn more about partnering with PHA through Building Medical Education in PH for your next CME event, email


PHA 30-City Program

PHA's 30-City program visits areas without nationally recognized PAH centers, providing physicians and other healthcare professionals with the latest information on the diagnosis and management of PAH.
See a complete list of the 30-City programs

The following 30-City events will take place in October, November, and December:

» October 26: Roanoke, Va. (Terry A. Fortin, MD, MS, Duke University)
» November 2: Phoenix, Ariz. (Gregory S. Ahearn, MD, Arizona Pulmonary Specialists)
» November 17: Savannah, Ga. (James R. Gossage, MD, Medical College of Georgia)
» December 7: Austin, Texas (Deborah J. Levine, MD, UT Health Science Center)

Register now


PHA Preceptorship Program

PHA's Preceptorship program is offered at nationally recognized PAH centers with direct instruction on state-of-the-art PAH diagnosis and management for physicians and other health professionals who help care for patients with PAH. These day-long highly interactive preceptorships build links among community PAH specialists, non-specialists, and clinicians at established PAH centers, creating new avenues for communication and more comprehensive, state-of-the-art diagnosis, initial treatment, and long-term management of patients with PAH.

See a complete list of the Preceptorship programs

The following Preceptorship events will take place in November and December:
» November 4: Aurora, Colo. (University of Colorado Denver)
» November 4: Pittsburgh, PA (University of Pittsburgh & Allegheny General Hospital)
» November 4: Seattle, Wash. (University of Washington Medical Center)
» December 2: Chicago, Ill. (University of Chicago Medical Center)
» December 2: Pittsburgh, PA (University of Pittsburgh & Allegheny General Hospital)
» December 9: Atlanta, Ga. (Emory University & Harvard Medical School)

Register now

News and Information

Participants in the NIH Loan Repayment Programs Receive Up to $35,000 Annually to Help Repay Student Loans

The 2012 application cycle for the National Institutes of Health's Loan Repayment Programs (LRPs) is now open. The LRPs repay the outstanding student loans of researchers who are or will be conducting nonprofit biomedical or behavioral research. Opportunities are available in five research areas – clinical, pediatric, health disparities, contraception and infertility and clinical research for individuals from disadvantaged backgrounds. Applications will be accepted until 8:00 p.m. ET on November 15, 2011. Access the application
Submission Deadline: November 15, 2011


Safety Considerations for Administering Intravenous Prostacyclins to Pulmonary Hypertension Patients in the Hospital Setting

The following recommendations are the result of the findings from a national telephone and national electronic survey of PH centers by Kingman, (2010) and are not intended to supersede individual hospital policies. The intent of this document is to suggest safety measures that have been helpful in facilities treating patients with pulmonary hypertension. Read more

Sprycel (dasatinib): Drug Safety Communication - Risk of Pulmonary Arterial Hypertension

FDA has notified healthcare professionals that Sprycel (dasatinib) may increase the risk of pulmonary arterial hypertension (PAH). In reported cases, patients developed PAH after starting Sprycel, including after more than one year of treatment.Information about this risk has been added to the Warnings and Precautions section of the Sprycel drug label. Read the press release and access the report


Medical Education On-Demand Program

Design your own free, CME-accredited PH medical education program for your colleagues. You choose the PH-related topic, expert speaker, meeting format and date based on the needs of your community, and PHA will take care of the rest! Visit for more information!


Featured Courses in
PHA Online University

Free, CME-accredited courses for medical professionals interested in PH. Full course catalog available at

PHA recorded 26 sessions at the 4th Annual International Neonatal and Childhood Pulmonary Vascular Disease Conference. The first 11 recordings are available for .5 to 1.0 hours of CME credit on the PHA Online University. Check out this great opportunity.
 » Take a course

Conferences of Interest

October 20-22, 2011
Beryllium Summit 2011 4th International Conference
InterContinental Hotel Cleveland, Ohio
October 22-26, 2011
American College of CHEST Physicians Annual Meeting
Honolulu, Hawaii
October 28-29, 2011
Pittsburgh International Lung Conference; Personalized Medicine of Lung Disease
Pittsburgh, Pennsylvania
November 4-9, 2011
American College of Rheumatology: Annual Scientific Meeting
Chicago, Illinois
November 6-8, 2011
Pulmonary Hypertension Summit 2011
InterContinental Hotel Cleveland, Ohio
(PHA Building Medical Education in PH Event)
November 15-17, 2011
2nd World Orphan Drug Summit
Boston, Massachusetts

» Go to PHA's Medical Education Calendar


Contact Us

If you have research opportunities, upcoming conferences or other information to share in future editions of PH Research Roundup, or need any additional information, please email

Need more information? Contact
Pulmonary Hypertension Association 801 Roeder Road, Ste. 1000 Silver Spring, MD 20910
Office: 301-565-3004 | Fax: 301-565-3994

PH Research Roundup is a membership benefit for PH Clinicians and Researchers and PH Resource Network.
If you wish to UNSUBSCRIBE from PH Research Roundup: Email with "Unsubscribe Research Roundup" in the subject or message.

Privacy Policy | Email Preferences

Copyright © 2011 Pulmonary Hypertension Association.
All Rights Reserved.

FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs. PHA does not endorse or recommend any commercial products or services.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Terms of Use    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2017 Pulmonary Hypertension Association. All Rights Reserved.

BBB Accredited Charity BEST in AmericaCharity Navigator

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.